Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study Quincy Bioscience, a research-based biotechnology company, announced interim results from the Preva - Clinical study design - Document - PDFSEARCH.IO

First Page	Meta Content
	Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study Quincy Bioscience, a research-based biotechnology company, announced interim results from the Preva Add to Reading List Document Date: 2010-11-01 19:54:50 Open Document File Size: 134,80 KB Share Result on Facebook City Madison / / Company Cogstate Ltd. / Quincy Bioscience / Placebo-Controlled Memory Study Quincy Bioscience / Puget / PRWeb / / Facility University of Wisconsin-Milwaukee / / IndustryTerm Online Web / research-based biotechnology / biotechnology / online visibility tool / online version / / MedicalCondition neurodegenerative disorders / / Organization University of Wisconsin-Milwaukee / / Person Lerner / Mark Underwood / Quincy Bioscience Announces Encouraging / / / Position President / Manager of Business Development / / ProvinceOrState Wisconsin / / Technology biotechnology / / URL http / SocialTag Research Medicine Design of experiments Bioethics Medical ethics Vocus Placebo-controlled study Placebo Clinical trial Clinical research

Quincy Bioscience Announces Encouraging Preliminary Results of Randomized, Double-Blind, Placebo-Controlled Memory Study Quincy Bioscience, a research-based biotechnology company, announced interim results from the PrevaAdd to Reading List